Washington Medicaid’s Subscription-Based Payment Model For Hepatitis C Medications Increased HCV Prescription Fills By 16%

Washington Medicaid’s subscription-based payment model (SBPM) for hepatitis C virus (HCV) medications led to a 16.2% increase in HCV prescription fills. After Washington launched its SBPM with AbbVie Inc. for access to Mavyret in 2019, the number of HCV prescription fills for Mavyret translated to an estimated increase of 3.8 quarterly prescription fills per 100,000 Medicaid enrollees.

Washington used a two-part pricing model for its five-year contract with AbbVie Inc. The state pays a reduced price per prescription through supplemental rebates up to a certain spending threshold. After hitting this threshold, the per . . .